Veterinary Medicines

Levaveto 750 mg/g Powder for use in drinking water

Authorised
  • Levamisole hydrochloride
Download as PDF

Product identification

Medicine name:
Levaveto 884 mg/g Proszek do podania w wodzie do picia
Levaveto 750 mg/g Powder for use in drinking water
Active substance:
  • Levamisole hydrochloride
Target species:
  • Pig
Route of administration:
  • In drinking water use

Product details

Active substance and strength:
  • Levamisole hydrochloride
    884.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Powder for use in drinking water
Withdrawal period by route of administration:
  • In drinking water use
    • Pig
      • Meat and offal
        21
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AE01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Poland
Package description:
  • Levaveto 750 mg/g pwdr. for drinking water 10 x 100 g
  • Levaveto 750 mg/g pwdr. for drinking water 1000 g
  • Levaveto 750 mg/g pwdr. for drinking water 100 g

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 8(3) of Directive No 2001/83/EC)
Marketing authorisation holder:
  • V.M.D.
Marketing authorisation date:
Manufacturing sites for batch release:
  • V.M.D.
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 2851
Date of authorisation status change:
Reference member state:
  • Belgium
Procedure number:
  • BE/V/0034/001
Concerned member states:
  • Estonia
  • France
  • Germany
  • Hungary
  • Latvia
  • Lithuania
  • Netherlands
  • Poland
  • Romania
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."